Tinzaparin: all 36 studies that test it
Page 1 of 1. Open to participants first (7), then studies with results posted, then the rest; newest registration first within each.
- The OAT Trail: The Obesity Anti-Coagulation Thromboprophylaxis Trial.Not yet recruitingNCT07559643Not applicable
- LDA and LMWH vs LDA Alone in High-risk Patients for Preeclampsia PreventionRecruitingNCT07361679Phase 4
- Thromboprophylaxis in Lower Limb ImmobilisationRecruitingNCT06370273Phase 3
- THRomboprophylaxis in Individuals Undergoing Superficial endoVEnous Treatment (THRIVE)RecruitingNCT05735639Phase 4
- Tinzaparin And Biomarkers After Neoadjuvant Treatment of Ovarian CancerRecruitingNCT05284552Phase 2
- STrategies for Anticoagulation in Patients With thRombocytopenia and Cancer-associated ThrombosisRecruitingNCT05255003Phase 4
- Pre- Vs. Postoperative Thromboprophylaxis in Pancreatic SurgeryRecruitingNCT05245877Phase 4
- Innohep® in Elderly Patients With Impaired Renal Function Treated for Acute Deep Vein ThrombosisCompletedNCT00277394Phase 4Results posted
- Combination Anti-Platelet and Anti-Coagulation Treatment After Lysis of Ischemic Stroke Trial (CATALIST)CompletedNCT00061373Phase 2Results posted
- TINzaparin Prophylaxis in Patients With Metastatic Colorectal CancerCompletedNCT05625932Phase 3
- The Impact of Thromboprophylaxis on Progression Free Survival of Patients With Advanced Pancreatic CancerStatus unknownNCT05178628Phase 3
- Tinzaparin Lead-In to Prevent the Post-Thrombotic SyndromeTerminatedNCT04794569Phase 4
- Effect of Tinzaparin on Inflammatory Biomarkers During the Acute Phase of Deep Vein ThrombosisActive, not recruitingNCT04741464Not applicable
- Standard vs High Prophylactic Doses or Anticoagulation in Patients With High Risk of Thrombosis Admitted With COVID-19 Pneumonia (PROTHROMCOVID)CompletedNCT04730856Not applicable
- Australasian COVID-19 Trial (ASCOT) ADAptive Platform TrialActive, not recruitingNCT04483960Phase 3
- Prophylaxis of Venous Thromboembolism in Advanced Lung Cancer (PROVE)TerminatedNCT03090880Phase 3
- Therapeutic Anticoagulation Strategy for Acute Chest SyndromeCompletedNCT02580773Phase 3
- Effects of Anticoagulant Preventive Injection in Patients With Blood CancerCompletedNCT02260414Phase 2
- Use of Tinzaparin for Anticoagulation in HemodialysisCompletedNCT01930396Phase 4
- Comparison of Low and Intermediate Dose Low-molecular-weight Heparin to Prevent Recurrent Venous Thromboembolism in PregnancyCompletedNCT01828697Phase 4
- Extended Peri-operative Tinzaparin to Improve Disease-free Survival in Patients With Resectable Colorectal CancerCompletedNCT01455831Phase 3
- Can Low Molecular Weight Heparin During Pregnancy With Intrauterine Growth Restriction Increase Birth Weight?CompletedNCT01390051Phase 4
- Long-Term Innohep® Treatment Versus a Vitamin K Antagonist (Warfarin) for the Treatment of Venous Thromboembolism (VTE) in CancerCompletedNCT01130025Phase 3
- Tinzaparin for Primary Treatment and Extended Secondary Prophylaxis of Venous Thromboembolism in Patients With CancerTerminatedNCT00981903Phase 2
- Thromboprophylaxis for Patients Undergoing Surgical Resection for Colon CancerCompletedNCT00967148Not applicable
- Safety and Efficacy of Therapeutic Anticoagulation With Tinzaparin During Pregnancy Via Weight-based DosingCompletedNCT00851864Phase 4
- Long-Term Low-Molecular-Weight Heparin Versus Oral Anticoagulants in Deep Venous ThrombosisCompletedNCT00689520Phase 4
- Innohep for Prophylaxis of Venous Thromboembolism in Brain Tumor PatientsCompletedNCT00629447Not applicable
- Evaluation of Long-Term Sequelae After Thrombophlebitis, i.e. Deep Venous Thrombosis of the Lower ExtremitiesCompletedNCT00628576Phase 3
- Tinzaparin in Treating Patients With Metastatic Kidney Cancer That Cannot Be Removed By SurgeryStatus unknownNCT00293501Phase 1/2
- A Comparison of Dalteparin and Tinzaparin for Prevention of Blood Clots in Hemodialysis Patients on Oral Anticoagulants Having SurgeryCompletedNCT00260988Phase 2/3
- The STOP CLOT Pilot Study: Study of Low Molecular Weight Heparin in High Risk Cesarean SectionCompletedNCT00225108Phase 2/3
- Assessment of Long-Term Out-of-Hospital Treatment of Patients With Proximal Deep Vein Thrombosis (DVT) Using Low-Molecular-Weight Heparin (LMWH) Versus LMWH Followed by WarfarinCompletedNCT00203658Phase 4
- Trial of the Effect of Low-Molecular-Weight Heparin (LMWH) Versus Warfarin on Mortality in the Long-Term Treatment of Proximal Deep Vein Thrombosis (DVT) (Main LITE Study)CompletedNCT00203580Phase 4
- Use of Low Molecular Weight Heparin (Tinzaparin) to Treat Blood Clots in Patients With Kidney FailureTerminatedNCT00186745Not applicable
- MesoHep II: Intraperitoneal Low Molecular Weight Heparin in Peritoneal DialysisTerminatedNCT00135863Not applicable